Exercise training prevents β-adrenergic hyperactivity-induced myocardial hypertrophy and lesions

European Journal of Heart Failure

Volumn 10, Issue 6, 2008, Pages 534-539

  Serra, Andrey J ^a   Higuchi, Maria L ^b   Ihara, Silvia S M ^a   Antônio, Ednei L ^a   Santos, Marília H H ^b   Bombig, Maria T N M ^a   Tucci, Paulo J F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardioprotection; Exercise training; Isoproterenol; Myocardial hypertrophy

Indexed keywords

ISOPRENALINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART MUSCLE INJURY; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREADMILL EXERCISE;

EID: 44649169681     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.03.016     Document Type: Article

References (25)

1. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77 (1988) 721-730
2. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 112 (2005) 154-235
3. Osadchii O.E. Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev 12 (2007) 66-86
4. Prabhu S., Jainu M., and Sabitha K.E. Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. Vascul Pharmacol 44 (2006) 519-525
5. Murray D.R., Prabhu S.D., and Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101 (2000) 2338-2341
6. Rona G., Chappel C.I., Balazs T., and Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 67 (1959) 443-455
7. Rathore N., John S., Kale M., and Bhatnagar D. Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res 38 (1998) 297-303
8. Okuda N., Hayashi T., Mori T., et al. Nifedipine enhances the cardioprotective effect of angiotensin-II receptor blocker in an experimental animal model of heart failure. Hypertens Res 28 (2005) 431-438
9. Gallego M., Espina L., and Vegas L. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats. Pharmacol Res 44 (2001) 311-315
10. Brouri F., Hanoun N., Mediani O., et al. Blockade of β1- and desensitization of β2-adrenoreceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol 485 (2004) 227-234
11. Ishizawa M., Mizushige K., Noma T., et al. An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic β-adrenergic stimulation rat model. Life Sci 78 (2006) 2974-2982
12. Lennon S.L., Quindry J.C., French J.P., Kim S., Mehta J.L., and Powers S.K. Exercise and myocardial tolerance to ischaemia-reperfusion. Acta Physiol Scand 182 (2004) 161-169
13. Freimann S., Scheinowitz M., Yekutieli D., Feinberg M.S., Eldar M., and Kessler I.G. Prior exercise training improves the outcome of acute myocardial infarction in the rat: heart structure, function, and gene expression. J Am Coll Cardiol 45 (2005) 931-938
14. Riggs C.E., Landiss C.W., Jessup G.T., and Bonner H.W. Effects of exercise on the severity of isoproterenol-induced myocardial infarction. Med Sci Sports 9 (1977) 83-87
15. Brodowicz G.R., and Lamb D.R. Exercise training, indomethacin, and isoproterenol-induced myocardial necrosis in the rat. Basic Res Cardiol 86 (1991) 40-48
16. Darrah M., and Engen R.L. Beneficial effects of exercise on l-isoproterenol induced myocardial infarction in male rats. Med Sci Sports Exerc 14 (1982) 76-80
17. Gerdes A.M., Liu Z., and Zimmer H.G. Changes in nuclear size of cardiac myocytes during the development and progression of hypertrophy in rats. Cardioscience 5 (1994) 203-208
18. Junqueira L.C.U., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11 (1979) 442-455
19. Gundersen H.J.G., Bendtsen T.F., Korbo L., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96 (1988) 379-394
20. Murad N., and Tucci P.J. Isoproterenol-induced hypertrophy may result in distinct ventricular changes. Clin Exp Pharmacol Physiol 27 (2000) 352-357
21. Benjamin I.J., Jalil J.E., Tan L.B., et al. Isoproterenol-induced myocardial fibrosis in relation to myocite necrosis. Circ Res 65 (1989) 657-670
22. Mann D.L. Basic mechanisms of disease progression in the failing heart: the role of excessive adrenergic drive. Prog Cardiovasc Dis 41 suppl 1 (1998) 1-8
23. Grimm D., Elsner D., Schunkert H., et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37 (1998) 91-100
24. Zhou B., Wu L.-J., Li L.-H., Tashiro S.-I., Onodera S., Uchiumi F., and Ikejima T. Silibinin protects against isoproterenol-Induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1. J Pharmacol Sci 102 (2006) 387-395
25. Teerlink J.R., Pfeffer J.M., and Pfeffer M.A. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75 (1994) 105-113